IMARC Group, a leading market research company, has recently releases report titled “Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global oligonucleotide synthesis market size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Oligonucleotide Synthesis Market?
Report Attributes | Details |
Market Size in 2022 | US$ 2.7 Billion |
Market Forecast in 2028 | US$ 5.5 Billion |
Growth rate (2023 to 2028) | CAGR of 12.76% |
Base Year of the Analysis | 2022 |
Forecast Period | 2023-2028 |
What is Oligonucleotide Synthesis?
Oligonucleotide synthesis refers to an essential process in molecular biology and biotechnology that involves the chemical synthesis of short sequences of nucleotides. It includes solid-phase, solution-phase, enzymatic, microarray, and gene synthesis. Oligonucleotide synthesis is widely used in deoxyribonucleic acid (DNA) sequencing, polymerase chain reaction (PCR) amplification, diagnostics, therapeutics, and molecular research. It allows scientists to create custom-designed DNA or ribonucleic acid (RNA) sequences with precise nucleotide composition. Oligonucleotide synthesis also provides high levels of purity, ensuring accurate and reliable results in downstream applications. It also offers fast turnaround times, allowing researchers to obtain the required oligonucleotides in a timely manner.
Request for a Free PDF Sample Report: https://www.imarcgroup.com/oligonucleotide-synthesis-market/requestsample
What Are the Growth Prospects and Trends in the Oligonucleotide Synthesis Market?
The increasing demand for personalized medicine and targeted therapeutics is fueling the market growth. Oligonucleotide synthesis is widely used in the development of gene-based therapies, including antisense oligonucleotides, small interfering RNAs (siRNAs), and messenger RNA (mRNA)-based drugs, which aids in the treatment of various genetic disorders, cancers, and rare diseases. Furthermore, the increasing demand for high-throughput sequencing and genotyping is facilitating the adoption of oligonucleotide synthesis, as it enables the identification and analysis of genetic variations, gene expression patterns, and disease markers. Moreover, the widespread adoption of oligonucleotide synthesis in academic institutions, pharmaceutical companies, and biotech firms is contributing to market growth. Other factors, including the escalating prevalence of chronic ailments, increasing investment in the development of advanced synthesis processes, and growing demand for oligonucleotides in diagnostic tests, are anticipated to drive market growth.
Who Are the Key Players Operating in the Oligonucleotide Synthesis Market?
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Agilent Technologies Inc.
- Biolegio B.V.
- Bio-Synthesis Inc
- Eurofins Genomics
- GenScript
- Horizon Discovery Ltd
- Integrated DNA Technologies Inc (Danaher Corporation)
- Kaneka Eurogentec S.A. (Kaneka Corporation)
- LGC Limited
- Nitto Denko Avecia Inc (Nitto Denko Corporation)
- Thermo Fisher Scientific Inc.
What is Included in Market Segmentation?
The report has categorized the market based on product, application, end useand region.
Breakup by Product:
- Synthesized Oligonucleotide Products
- Reagents
- Equipment
- Services
Based on Application:
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In-Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Others
Analysed by End Use:
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic Research Institutes
Regional Analysis:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Website: https://www.imarcgroup.com/
Follow us on twitter: @ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group
